Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
OPT-80
DRUG
2 trials
Sponsors
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
, Astellas Pharma Inc
Conditions
Clostridium Difficile
Diarrhea
Phase 2
OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)
Completed
NCT00097422
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Diarrhea
Start: 2004-11-01
End: 2005-04-01
Updated: 2017-03-27
Phase 3
A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
Completed
NCT02179658
Astellas Pharma Inc
Clostridium Difficile
Start: 2014-06-23
End: 2016-09-08
Updated: 2024-10-31
Related Papers
Antimicrobial Susceptibility and Molecular Characterization Using Whole-Genome Sequencing of Clostridioides difficile Collected in 82 Hospitals in Japan between 2014 and 2016
Antimicrobial Agents and Chemotherapy
2019-09-17
30 citations
Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan
Journal of Infection and Chemotherapy
2018-06-19
83 citations